Skip to content

Michael Torres Lizardi, MD

NPI 1326440496ActiveIndividual· Internal Medicine, Pulmonary Disease· Springfield, MA

Internal Medicine, Pulmonary Disease (MD) in Springfield, Massachusetts, trained at University of Puerto Rico School of Medicine (class of 2015). Part D covered 285 prescriptions written in 2024, 34% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 3 companies reporting payments in 2024, $475.59 in all, mostly food and beverage.

Overview

NPI1326440496
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedSep 20, 2014
Last updated in NPPESAug 21, 2026
Certified by providerAug 21, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pulmonary Disease (MA)

Part D prescriptions in 2024

Prescriptions (claims)285 · 406 30-day fills
Patients56
Total drug cost$73,238
Generic share34% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of Puerto Rico School of Medicine
Graduation year2015
Medicare specialtyPulmonary Disease

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2024$475.59 · 6 payments from 3 companies

Top paying companies in 2024

What the 2024 payments were for

  • Food and Beverage$475.59 · 6 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other pulmonologists in Springfield

All 30 pulmonologists in Springfield · All pulmonologists in Massachusetts